DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Method for identifying type I diabetes mellitus in humans

Abstract

A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.

Inventors:
 [1];  [2];  [3];  [2]
  1. Kennewick, WA
  2. Richland, WA
  3. Pasco, WA
Issue Date:
Research Org.:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1016737
Patent Number(s):
7923253
Application Number:
US Patent Application 12/291,173
Assignee:
Battelle Memorial Institute (Richland, WA)
Patent Classifications (CPCs):
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
DOE Contract Number:  
AC05-76RLO1830
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Metz, Thomas O, Qian, Weijun, Jacobs, Jon M, and Smith, Richard D. Method for identifying type I diabetes mellitus in humans. United States: N. p., 2011. Web.
Metz, Thomas O, Qian, Weijun, Jacobs, Jon M, & Smith, Richard D. Method for identifying type I diabetes mellitus in humans. United States.
Metz, Thomas O, Qian, Weijun, Jacobs, Jon M, and Smith, Richard D. Tue . "Method for identifying type I diabetes mellitus in humans". United States. https://www.osti.gov/servlets/purl/1016737.
@article{osti_1016737,
title = {Method for identifying type I diabetes mellitus in humans},
author = {Metz, Thomas O and Qian, Weijun and Jacobs, Jon M and Smith, Richard D},
abstractNote = {A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2011},
month = {4}
}

Works referenced in this record:

Salivary protein profiling in type I diabetes using two-dimensional electrophoresis and mass spectrometry
journal, March 2006